Mycophenolate mofetil is effective for maintenance therapy of systemic vasculitis
ASN 30th Annual Meeting, San Antonio
J Am Soc Nephrol (Sep) 8:95A 1997
Serious complications of long-term cyclophosphamide therapy have been reported. Thus an alternate agent for maintenance therapy is desirable. In a multi-center pilot study of patients with vasculitis, mycophenolate mofetil (MMF) was given with tapering steroid doses for 15 months after remission with steroids and cyclophosphamide. No relapses have occurred.
Comment: These are pilot data with small numbers but are encouraging. (David J. Leehey, M.D., Loyola University at Chicago)
To go back use the BACK button on your browser. Otherwise click on the desired link to this article below:
ASN 30th Annual Meeting, San Antonio
Proteinuria/Hematuria : Vasculitis (Wegener's PAN, etc.)